CPSC2019-04-25
TriDerma Recalls Pain Relief Cream Due to Failure to Meet Child Resistant Closure Requirement; Risk of Poisoning (Recall Alert)
Product photos
Hazard
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
Remedy
Consumers should immediately store the topical anesthetic in a safe location, out of reach of children and contact TriDerma for a free replacement child-resistant cap. TriDerma is contacting all known purchasers directly.
Sold at
www.triderma.com from January 2018 through April 2019 for about $22 for the jar and about $15 for the tube.
Affected count
About 410
Injuries reported
None reported.
Manufactured in
United States
Remedy type
Replace
Products
Pain Relief Cream with Lidocaine
Consumer contact
TriDerma at 800-279-7282 from 7 a.m. to 4:30 p.m. PT Monday to Friday, email at marilyn@triderma.com or online at www.triderma.com and click on Customer Service for more information.
Official notice
https://www.cpsc.gov/Recalls/2019/TriDerma-Recalls-Pain-Relief-Cream-Due-to-Failure-to-Meet-Child-Resistant-Closure-Requirement-Risk-of-Poisoning-Recall-AlertDon't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief